Opdivo

Made by

• Ono Pharmaceutical

Active Ingredient

Nivolumab

Prospectus

Approval date

2014/7/4

Treats

• Hodgkin lymphoma
• Malignant pleural mesothelioma
• Melanoma
• Colorectal cancer
• Gastric cancer
• Renal cell carcinoma
• Non-small cell lung cancer
• Head and neck cancer
• Esophageal cancer

Dosages

• OPDIVO I.V.Infusion - 31918円／瓶

• OPDIVO I.V.Infusion - 155072円／瓶

• OPDIVO I.V.Infusion - 185482円／瓶

• OPDIVO I.V.Infusion - 366405円／瓶